Cargando…

Artificial intelligence assists identifying malignant versus benign liver lesions using contrast‐enhanced ultrasound

BACKGROUND AND AIM: This study aims to construct a strategy that uses assistance from artificial intelligence (AI) to assist radiologists in the identification of malignant versus benign focal liver lesions (FLLs) using contrast‐enhanced ultrasound (CEUS). METHODS: A training set (patients = 363) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Hang‐Tong, Wang, Wei, Chen, Li‐Da, Ruan, Si‐Min, Chen, Shu‐Ling, Li, Xin, Lu, Ming‐De, Xie, Xiao‐Yan, Kuang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518504/ https://www.ncbi.nlm.nih.gov/pubmed/33880797 http://dx.doi.org/10.1111/jgh.15522

Ejemplares similares

An artificial intelligence ultrasound system’s ability to distinguish benign from malignant follicular-patterned lesions
por: Xu, Dong, et al.
Publicado: (2022)

Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
por: Che, Li, et al.
Publicado: (2020)

Articles That Use Artificial Intelligence for Ultrasound: A Reader’s Guide
por: Kuang, Ming, et al.
Publicado: (2021)

Scoping review of clinical practice guidelines on the management of benign liver tumours
por: Haring, Martijn P D, et al.
Publicado: (2021)

Contrast-enhanced ultrasound of benign and malignant liver lesions in children
por: Fang, Cheng, et al.
Publicado: (2021)

Application of ultrasound artificial intelligence in the differential diagnosis between benign and malignant breast lesions of BI-RADS 4A
por: Niu, Sihua, et al.
Publicado: (2020)

Trials in developing a nanoscale material for extravascular contrast-enhanced ultrasound targeting hepatocellular carcinoma
por: Wu, Size, et al.
Publicado: (2020)

Antiviral therapy effectively improves liver hemodynamics as evidenced by serum biomarker and contrast-enhanced ultrasound examinations in patients with hepatitis B cirrhosis
por: Xu, Xiaoyong, et al.
Publicado: (2018)

Artificial Intelligence-Based Multiclass Classification of Benign or Malignant Mucosal Lesions of the Stomach
por: Ma, Bowei, et al.
Publicado: (2020)

Discriminative deep learning based benignity/malignancy diagnosis of dermatologic ultrasound skin lesions with pretrained artificial intelligence architecture
por: Laverde‐Saad, Alexandra, et al.
Publicado: (2021)

Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma
por: Liu, Jinkai, et al.
Publicado: (2022)

Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients
por: Zhang, Chao, et al.
Publicado: (2023)

Acute kidney injury after multiphase imaging for lesions detected on hepatocellular carcinoma surveillance in patients with cirrhosis
por: Khan, Adnan Aman, et al.
Publicado: (2020)

A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study
por: Dai, Yuhong, et al.
Publicado: (2023)

Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classification for the differentiation of benign from malignant lesions of thyroid nodules
por: Zhang, Yan, et al.
Publicado: (2016)

Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
por: Lee, Yi-Chia, et al.
Publicado: (2013)

Artificial Intelligence Algorithms for Benign vs. Malignant Dermoscopic Skin Lesion Image Classification
por: Brutti, Francesca, et al.
Publicado: (2023)

Duodenal Subepithelial Lesion? An Unexpected Endoscopic Ultrasound Finding
por: Marques, Susana, et al.
Publicado: (2015)

A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
por: Chan, Tim Hon Man, et al.
Publicado: (2014)

SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice
por: Liu, Chih-Wei, et al.
Publicado: (2020)

Clinical value and application of contrast-enhanced ultrasound in the differential diagnosis of malignant and benign breast lesions
por: Zhang, Yan, et al.
Publicado: (2020)

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index
por: Liu, Ta-Wei, et al.
Publicado: (2020)

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
por: Rao, Jianhua, et al.
Publicado: (2022)

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice
por: Zhang, Tian-Ying, et al.
Publicado: (2020)

Artificial liver research output and citations from 2004 to 2017: a bibliometric analysis
por: Li, Yan, et al.
Publicado: (2019)

Differentiation of malignant from benign pleural effusions based on artificial intelligence
por: Wang, Sufei, et al.
Publicado: (2023)

The association between serum folate and ultrasound - defined hepatic steatosis
por: Chen, Xingxing, et al.
Publicado: (2023)

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
por: Li, Jiang, et al.
Publicado: (2022)

Triple-phase MDCT of liver: Scan protocol modification to obtain optimal vascular and lesional contrast
por: Sween, Sheoran, et al.
Publicado: (2018)

Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway
por: Li, Meng, et al.
Publicado: (2018)

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
por: Xiong, Zhewen, et al.
Publicado: (2023)

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation
por: Yuan, Lunzhi, et al.
Publicado: (2019)

Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury
por: Arriazu, Elena, et al.
Publicado: (2017)

High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions
por: Fei, Xiang, et al.
Publicado: (2022)

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma
por: Shang, Runze, et al.
Publicado: (2021)

Application of Quantitative Parameters of Contrast-Enhanced Ultrasound in Common Benign and Malignant Lesions in Pediatric Livers: A Preliminary Study
por: Han, Dan, et al.
Publicado: (2023)

Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study
por: Wang, Kun, et al.
Publicado: (2019)

PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma
por: Lu, Li-Gong, et al.
Publicado: (2022)

Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection
por: Rao, Huiying, et al.
Publicado: (2014)

Endoscopic ultrasound versus endoscopic retrograde cholangiopancreatography-guided biliary drainage for primary decompression of malignant biliary obstruction: protocol for a systematic review and meta-analysis of randomised controlled trials
por: Jin, Zheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_03g8gh4rfp565nuhoq5kd69oev